Dipeptidyl peptidase-4 inhibitor use is associated with a lower erythrocyte sedimentation rate in patients with remitting seronegative symmetrical synovitis with pitting oedema and pre-existing diabetes mellitus

Yoshiro Horai,Toshimasa Shimizu,Akitomo Okada,Junichi Tokumitsu,Toshiyuki Ikeoka,Genpei Kuriya,Nozomi Iwanaga,Yasumori Izumi,Tomoki Origuchi,Atsushi Kawakami

MODERN RHEUMATOLOGY（2022）

引用 2|浏览4

暂无评分

关键词

Diabetes mellitus, dipeptidyl peptidase-4 inhibitors, erythrocyte sedimentation rate, inflammation, remitting seronegative symmetrical synovitis with pitting oedema syndrome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要